Lanreotide NEW

Profile:

anreotide is a synthetic peptide analog of somatostatin, a naturally occurring inhibitory hormone which suppresses the secretion of growth hormone and various other hormones throughout the body. Lanreotide functions similarly to somatostatin but with a longer duration of action. 

It is primarily used in medicine for the treatment of acromegaly, a condition characterized by excessive growth hormone production, leading to enlarged features and numerous health complications. 

Additionally, lanreotide is utilized in managing symptoms associated with neuroendocrine tumors (NETs), particularly those that affect the gastrointestinal tract and pancreas.

Lanreotide is administered via deep subcutaneous injection typically once every 4 weeks; however, dosing may vary based on individual patient needs or specific conditions being treated. Side effects can include gastrointestinal disturbances such as diarrhea or abdominal pain, gallstones due to changes in bile composition, glucose metabolism alterations leading to diabetes or hypoglycemia risks among others.

Developed for its targeted action and prolonged effect profile compared to natural somatostatin, lanreotide offers an important therapeutic option for patients dealing with certain hormonal disorders requiring long-term management.

Reference quality standards:

Appearance: white powder

Purity(HPLC): ≥98.0%

Single impurity: ≤1.0%

Acetate content: 5.0%～12.0

Moisture content: ≤10.0

Product Forms: Injectable Solution, Oral Capsules/Tablets, Solution/Drops

Related peptides: Semax, Noopept, Cortecin, BPC-157, etc.

Payment method: T/T in advance, Paypal, Western Union, L/C, etc.

Shipping ways: Courier, Air, Sea, Road

Storage Condition: Dry, dark, and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years)